|
Post by mnholdem on Jan 3, 2017 18:33:44 GMT -5
I think that MannKind's pre-IND work for RLS probably involves initially selecting the best formulation(s) for the API, such as stability, ease of manufacturing, storage (temperature), aerodynamics of the loaded particles and so forth. The next step in the typical pre-IND work may involve virtual and/or animal testing. More milestone payments will be forthcoming as these pre-IND steps progress, IMO...
|
|
|
Post by sayhey24 on Jan 3, 2017 19:17:00 GMT -5
I thought today's announcement was awesome. Considering RLS is picking up all R&D costs including MNKD labor a $1M payment is just icing on the cake. What today's announcement says is RLS/MNKD is not only real but has now setup the clinical manufacturing environment to brew the CBD/TCH combo and place it on Technosphere. I suspect they replicated the clinical manufacturing environment MNKD had for afrezza trials. If so I suspect human trials are not far behind and should go pretty quick. CBD/THC/FDKP are all known entities. What separates this combo apart from the GWPH's is the ability to precisely dose plus the cricket is cool. Now,GWPH has a market cap of $2.8B and MNKD's is $302M or a $5 adder to the current pps. If RLS can bring financial stability to MNKD, it will remove one more roadblock in the way of afrezza. I suspect the majority of the remaining $101M will not come until FDA approval.
|
|
|
Post by kbrion77 on Jan 3, 2017 19:21:19 GMT -5
Nobody even knows how RLS expects to finance any of their operations yet some were expecting $10MM or more in a developmental milestone, just be happy the check cashed right now. Do we have positive confirmation about the check clearing? Just something else to fret over. Maybe we should hope it was a wire then......
|
|
|
Post by broncolife on Jan 3, 2017 19:26:41 GMT -5
I know I'm gonna catch hell for this, but stop whining! People were whining when there was no PR. People whining when RLS was in the dark. Now we have consecutive milestone payments, albeit small, and people are whining. RLS is about to give a presentation at the Emerald Conference in California, which pretty much means they are in the Cannabis space. People still whining! Sooner or later some of you are going to have to stop sitting on the fence, eventually your ass starts to hurt. If your offended by this, then you are one of the whiners I am referring too. Good luck to everyone else!
P.S. No one is stopping you from selling and no one would blame you if you did! 😁
|
|
|
Post by kc on Jan 3, 2017 19:27:03 GMT -5
Must have been a reason to book it in 2016 for either Mannkind or RLS.
|
|
|
Post by dreamboatcruise on Jan 3, 2017 19:27:55 GMT -5
How about the fact that RLS making progress and it is getting this much closer to market being great and great news for MNKD. Well, 'making progress' is a vague term and everyone wants to see sales or real new short-term business opportunity in a significant market. I always found the MLS payment irrelevant in its size as it wasn't realistic that it would have an effect on the runway, whether 1m 5m or 10m. I hope that RLS would give more information about their business. That would have really helped the share price and my Jan17 options. But RLS remains in the dark. At least we know that they could get 1m in cash. If it had been $10M not only does that last a full month (a month is a month)... it also might be that some other technosphere deals might be announced and then the expectation would probably be for meaningful but not huge first milestone payments. With this being so small it would seem to remove the realistic expectation that any company bringing their own API wanting access to technosphere is going to bring with them enough cash in short term to contribute at all to mitigating current risk of significant dilution raising equity backed money. It may be that they avoided giving details of RLS milestones specifically hoping they might do some other deals before it became public. I would expect it becomes harder to negotiate for higher milestone payments once a company has seen previous deals that have been agreed to. I guess I had not given up on a few technosphere deals collectively making some difference to our cash flow problem in 2017. I have now been disabused of that optimism.
|
|
|
Post by madog365 on Jan 3, 2017 19:31:35 GMT -5
[quote author=" matt" Either there is material news ready and waiting that will push the price above $1 in the next few weeks, or Matt has to be getting ready to call the special meeting. Bumping to the OTC would kill the company. [/quote] I have to call you out here once again. This is a classic Matt post reminiscent of when you said the company would declare bankruptcy before the q3 earnings call. Now you are saying if the company doesn't announce material news in the next few weeks to get the share price above $1 , then a reverse split must be done or bankrupcy is inevitable. Wow all this on the first trading day of the year. You truly are a visionary. Get a grip.
|
|
|
Post by falconquest on Jan 3, 2017 19:44:59 GMT -5
Sayhey: "If so, I suspect human trials are not far behind and should go pretty quick".
With the incoming administration, I would not be too sure of anything right now regarding the FDA. There is no way to predict FDA approval times at this point.
broncolife: "Sooner or later some of you are going to have to stop sitting on the fence, eventually your ass starts to hurt. If your offended by this, then you are one of the whiners I am referring too".
My response to this is that while licensing deals are beneficial and I hope we develop more of them, it is clear that this is not a short term solution but a long term strategy. I'll sit the fence for now thank you.
dreamboatcruise: "With this being so small it would seem to remove the realistic expectation that any company bringing their own API wanting access to technosphere is going to bring with them enough cash in short term to contribute at all to mitigating current risk of significant dilution raising equity backed money".
Precisely!
I will say it one more time. WE NEED TO SELL AFREZZA!
|
|
|
Post by promann on Jan 3, 2017 19:49:27 GMT -5
I know I'm gonna catch hell for this, but stop whining! People were whining when there was no PR. People whining when RLS was in the dark. Now we have consecutive milestone payments, albeit small, and people are whining. RLS is about to give a presentation at the Emerald Conference in California, which pretty much means they are in the Cannabis space. People still whining! Sooner or later some of you are going to have to stop sitting on the fence, eventually your ass starts to hurt. If your offended by this, then you are one of the whiners I am referring too. Good luck to everyone else! P.S. No one is stopping you from selling and no one would blame you if you did! 😁 Nice post!! Either be happy with your investment or get out so we don't have to hear your whining..
|
|
|
Post by mnkdfann on Jan 3, 2017 20:04:35 GMT -5
I know I'm gonna catch hell for this, but stop whining! People were whining when there was no PR. People whining when RLS was in the dark. Now we have consecutive milestone payments, albeit small, and people are whining. RLS is about to give a presentation at the Emerald Conference in California, which pretty much means they are in the Cannabis space. People still whining! Sooner or later some of you are going to have to stop sitting on the fence, eventually your ass starts to hurt. If your offended by this, then you are one of the whiners I am referring too. I know I'm going to catch heck for this, but your post complaining about whiners comes across as a little whiny.
|
|
|
Post by sayhey24 on Jan 3, 2017 20:10:44 GMT -5
Sayhey: "If so, I suspect human trials are not far behind and should go pretty quick". With the incoming administration, I would not be too sure of anything right now regarding the FDA. There is no way to predict FDA approval times at this point. broncolife: "Sooner or later some of you are going to have to stop sitting on the fence, eventually your ass starts to hurt. If your offended by this, then you are one of the whiners I am referring too". My response to this is that while licensing deals are beneficial and I hope we develop more of them, it is clear that this is not a short term solution but a long term strategy. I'll sit the fence for now thank you. dreamboatcruise: "With this being so small it would seem to remove the realistic expectation that any company bringing their own API wanting access to technosphere is going to bring with them enough cash in short term to contribute at all to mitigating current risk of significant dilution raising equity backed money". Precisely! I will say it one more time. WE NEED TO SELL AFREZZA! As far as the FDA, could it get any worse? I suspect trying to sell afrezza the old fashion way is not going to work. This is the same discussion I had with Mike C last June at the annual meeting. I suspect Stefan Schwarz came to the same conclusion not long after the Sanofi launch. Just think if we had 100 Vdex-like clinics open today and each clinic wrote 5 new scripts a day. Mike might do better taking each of his sales guys and having each one open a clinic. I did notice Stefan finally changed his title on Linkedin to Alliance Management but was the VP, US Afrezza Lead until August 2016.
|
|
|
Post by mnkdfann on Jan 3, 2017 20:12:25 GMT -5
VALENCIA, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today confirmed that following the completion of initial formulation studies it received a $1 million milestone payment from Receptor Life Sciences, Inc. I just saw the above at SA and it gave me a chuckle. Hopefully people here see the humour and are not 'triggered' by the image above.
|
|
|
Post by cedafuntennis on Jan 3, 2017 20:31:00 GMT -5
I am disappointed by not the milestone amount but by the management 's handling of it. If the milestone amount is so small, why not set investor community's expectation's accordingly. The only time it makes sense to not set expectations is when there is a high probability of a positive surprise. IMO, this is not a good reflection on the management's competency. Indeed. Also the announcement was pathetic. No set expectations going forward, no goals just that he is looking forward. I am looking forward to seeing the New Year fireworks in 2210, but don't think that will happen. This is not good management Matt and you know it.
|
|
|
Post by cedafuntennis on Jan 3, 2017 20:35:30 GMT -5
At the burn rate of $10 million a month this should cover business expenses for 3 days. So basically $1 million will be depleted by the end of business day tomorrow. How about the fact that RLS making progress and it is getting this much closer to market being great and great news for MNKD. Not nearly enough. Keeping investors guessing with vague at best comments when the history has ALWAYS been disappointing is not good strategy, unless management really cannot give a squat on it's investors. Considering that there were some rather recent purchases by management, I am wondering if this is done due to plan or incompetence which is affecting upper management directly in their pockets as well.
|
|
|
Post by cedafuntennis on Jan 3, 2017 20:37:13 GMT -5
Wrong! They have another 180 days extension if they ask for one.
|
|